# A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors

> **NCT04707248** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Daiichi Sankyo** · enrollment: 179 (actual)

## Conditions studied

- Renal Cell Carcinoma
- Ovarian Tumor

## Interventions

- **DRUG:** DS-6000a
- **DRUG:** DS-6000a

## Key facts

- **NCT ID:** NCT04707248
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-12-22
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2025-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04707248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04707248, "A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04707248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*